Vujovic Olga, Yu Edward, Cherian Anil, Dar A Rashid, Stitt Larry, Perera Francisco
Department of Radiation Oncology, London Regional Cancer Centre, London, Ontario, Canada.
Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):760-4. doi: 10.1016/j.ijrobp.2005.08.004. Epub 2005 Oct 24.
This retrospective review was conducted to determine if delay in the start of radiotherapy after conservative breast surgery had any detrimental effect on local recurrence or disease-free survival in node-negative breast cancer patients.
A total of 568 patients with T1 and T2, N0 breast cancer were treated with breast-conserving surgery and breast irradiation, without adjuvant systemic therapy, between January 1, 1985 and December 31, 1992 at the London Regional Cancer Centre. The time intervals from definitive breast surgery to breast irradiation used for analysis were 0 to 8 weeks (201 patients), greater than 8 to 12 weeks (235 patients), greater than 12 to 16 weeks (91 patients), and greater than 16 weeks (41 patients). Kaplan-Meier estimates of time to local-recurrence and disease-free survival rates were calculated.
Median follow-up was 11.2 years. Patients in all 4 time intervals were similar in terms of age and pathologic features. No statistically significant difference was seen between the 4 groups in local recurrence or disease-free survival with surgery radiotherapy interval (p = 0.521 and p = 0.222, respectively). The overall local-recurrence rate at 5 and 10 years was 4.6% and 11.3%, respectively. The overall disease-free survival at 5 and 10 years was 79.6% and 67.0%, respectively.
This retrospective study suggests that delay in the start of breast irradiation of up to 16 weeks from definitive surgery does not increase the risk of recurrence in node-negative breast cancer patients. The certainty of these results is limited by the retrospective nature of this analysis.
进行这项回顾性研究,以确定保乳手术后放疗开始时间的延迟是否会对淋巴结阴性乳腺癌患者的局部复发或无病生存期产生任何不利影响。
1985年1月1日至1992年12月31日期间,共有568例T1和T2期、N0期乳腺癌患者在伦敦地区癌症中心接受了保乳手术和乳腺照射,未接受辅助全身治疗。用于分析的从确定性乳房手术到乳腺照射的时间间隔为0至8周(201例患者)、大于8至12周(235例患者)、大于12至16周(91例患者)和大于16周(41例患者)。计算了局部复发时间和无病生存率的Kaplan-Meier估计值。
中位随访时间为11.2年。所有4个时间间隔的患者在年龄和病理特征方面相似。手术放疗间隔在4组之间的局部复发或无病生存方面未见统计学显著差异(分别为p = 0.521和p = 0.222)。5年和10年的总体局部复发率分别为4.6%和11.3%。5年和10年的总体无病生存率分别为79.6%和67.0%。
这项回顾性研究表明,从确定性手术开始延迟长达16周进行乳腺照射不会增加淋巴结阴性乳腺癌患者的复发风险。这些结果的确定性受到该分析回顾性性质的限制。